DexCom, Inc. DXCM is well-positioned for growth in the coming quarters, supported by the significant potential of the ...
DexCom stock (NASDAQ: DXCM) currently trades at $73 per share, around 55% below the highs of $163 seen in November 2021. In comparison, Insulet stock (NASDAQ: PODD) saw its stock decline 39% over the ...